Cobra Biologics is a leading, international CMO providing a comprehensive biologics and pharmaceuticals service offering. With multi-functional and experienced project teams, the company nurtures its customers’ products from pre-clinical through to clinical supply and commercial manufacture.
Cobra has three GMP approved facilities for mammalian protein, microbial and virus production and a specialised fill and finish facility, each with expertise tailored to serving customers across the world. The company offers its customers a broad range of integrated and standalone contract manufacturing services stretching from cell line development to the fill and finish of drug products, taking pride in manufacturing excellence, delivering what is promised and helping customers to develop medicines for the benefit of patients.
Cobra supplies manufacturing solutions to the pharmaceutical industry covering antibodies, recombinant proteins, viruses, phage, DNA, whole cell vaccines and therapeutics as well as biologics and small molecule API lyophilisation and fill and finish into injectable vials or pre-filled syringes.
Visit the company’s brand new website for more information or to arrange a meeting with a member of the team at this year’s INTERPHEX.
Booth 1463, INTERPHEX 2014, 18–20 March 2014, Javits Center in New York City, US.
Cobra Biologics, +44 1782 714181, peter.coleman@cobrabio.com, www.cobrabio.com.